1. Home
  2. RRGB vs ADCT Comparison

RRGB vs ADCT Comparison

Compare RRGB & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Red Robin Gourmet Burgers Inc.

RRGB

Red Robin Gourmet Burgers Inc.

N/A

Current Price

$7.50

Market Cap

133.6M

ML Signal

N/A

Logo ADC Therapeutics SA

ADCT

ADC Therapeutics SA

N/A

Current Price

$1.10

Market Cap

136.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RRGB
ADCT
Founded
1969
2011
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
133.6M
136.1M
IPO Year
2002
2019

Fundamental Metrics

Financial Performance
Metric
RRGB
ADCT
Price
$7.50
$1.10
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$9.00
$7.75
AVG Volume (30 Days)
165.7K
1.1M
Earning Date
05-28-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
73.43
30.86
EPS
N/A
N/A
Revenue
$1,315,014,000.00
$81,357,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$66.49
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.85
52 Week Low
$2.46
$0.78
52 Week High
$8.26
$4.98

Technical Indicators

Market Signals
Indicator
RRGB
ADCT
Relative Strength Index (RSI) 66.13 30.93
Support Level $6.26 $0.78
Resistance Level $8.26 $1.17
Average True Range (ATR) 0.41 0.08
MACD -0.03 0.02
Stochastic Oscillator 91.01 6.12

Price Performance

Historical Comparison
RRGB
ADCT

About RRGB Red Robin Gourmet Burgers Inc.

Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. The company's brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. It has one operating and one reportable segment: restaurants.

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. Additionally, the company's development pipeline comprises LOTIS-2, LOTIS-5, LOTIS-7, and ADCT-241, being developed as potential therapies for different cancer diseases. Geographically, the firm generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

Share on Social Networks: